BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7926758)

  • 21. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
    Capobianco AJ; Gilmore TD
    Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB.
    Wilson MK; McWhirter SM; Amin RH; Huang D; Schlissel MS
    Mol Cells; 2010 Apr; 29(4):333-41. PubMed ID: 20213318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha.
    Arsura M; Wu M; Sonenshein GE
    Immunity; 1996 Jul; 5(1):31-40. PubMed ID: 8758892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.
    Miyamoto S; Chiao PJ; Verma IM
    Mol Cell Biol; 1994 May; 14(5):3276-82. PubMed ID: 8164680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
    Grumont RJ; Richardson IB; Gaff C; Gerondakis S
    Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
    Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A switch in distinct I kappa B alpha degradation mechanisms mediates constitutive NF-kappa B activation in mature B cells.
    Fields ER; Seufzer BJ; Oltz EM; Miyamoto S
    J Immunol; 2000 May; 164(9):4762-7. PubMed ID: 10779782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R; Nehyba J; Bose HR
    J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-rel activates but v-rel suppresses transcription from kappa B sites.
    Inoue J; Kerr LD; Ransone LJ; Bengal E; Hunter T; Verma IM
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3715-9. PubMed ID: 2023921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
    Nolan GP; Ghosh S; Liou HC; Tempst P; Baltimore D
    Cell; 1991 Mar; 64(5):961-9. PubMed ID: 2001591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages.
    Kuprash DV; Udalova IA; Turetskaya RL; Rice NR; Nedospasov SA
    Oncogene; 1995 Jul; 11(1):97-106. PubMed ID: 7624137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The precursor of NF-kappa B p50 has I kappa B-like functions.
    Rice NR; MacKichan ML; Israël A
    Cell; 1992 Oct; 71(2):243-53. PubMed ID: 1423592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
    Belich MP; Salmerón A; Johnston LH; Ley SC
    Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product.
    Chu ZL; McKinsey TA; Liu L; Qi X; Ballard DW
    Mol Cell Biol; 1996 Nov; 16(11):5974-84. PubMed ID: 8887627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.